Why this ASX 300 share could rise 32%

A top broker sees potential for big returns over the next 12 months.

The Australian share market has traditionally generated an annual return in the region of 10%.

But investors don't have to settle for that.

Not when there are ASX 300 shares out there with the potential to deliver outsized returns over the next 12 months.

But which share could be a buy? Bell Potter thinks the one in this article is worth considering.

Happy businessman fist pumping while looking at a tablet.

Image source: Getty Images

Which ASX 300 share?

Bell Potter is recommending GenusPlus Group Ltd (ASX: GNP) shares to clients. 

It is an Australian infrastructure services provider specialising in the end-to-end design, construction, and maintenance of electrical transmission networks, substations, battery energy storage systems, and telecommunications infrastructure.

Bell Potter highlights that the ASX 300 share has started FY 2027 in a positive fashion. It said:

GNP has started FY27 on a strong footing with several contract awards. We estimate GNP has converted 10% of its $3.6b FY26 tender pipeline value this financial year so far; the company has averaged a 62% conversion rate over FY23-FY25. Accounting for the recent contract awards, our FY27-28 revenue forecasts are now 5% and 18% uncontracted, respectively, compared with 7% and 24% previously. We make no changes to our forecasts in this report.

One contract is from mining giant Rio Tinto Ltd (ASX: RIO) and is estimated to be worth $55 million. It adds:

GNP has been awarded ~$350m of contracts this financial year to date. Firstly, GNP was contracted to construct the 220kV Millstream Substation expansion in the Pilbara region of WA by Rio Tinto, with the work package valued at ~$55m. Works are scheduled to complete in mid-CY28

Big potential returns

According to the note, the broker has retained its buy rating and $12.80 price target on the ASX 300 share.

Based on its current share price of $9.67, this implies potential upside of 32% for investors over the next 12 months.

Speaking about its buy recommendation, the broker said:

GNP is working through a record tender pipeline valued at $3.6b (as at FY26; up 50% YoY) across the transmission, BESS, rail and wind farm construction markets. GNP's FY27 PE of 19.1x is undemanding; we see potential for a re-rate towards 22-24x in the near-term, a justified premium to the peer group average. Catalysts to drive this multiple re-rate include: 1) a guidance upgrade (we view the FY27 guidance as conservative); 2) strong conversion of the tender pipeline; and 3) further M&A.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended GenusPlus Group. The Motley Fool Australia has recommended GenusPlus Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Thumbs down Facebook icon over dark screen.
Broker Notes

Why these 5 ASX shares were downgraded by brokers this week

Market analysts explain why they've downgraded these ASX stocks.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Domino's Pizza, Super Retail, PLS shares

Let's check out some new ratings on ASX shares today.

Read more »

Smiling woman taking a video through a plane window with her phone.
Broker Notes

Qantas or Virgin shares. Which ASX airline has more upside?

Will either share take off soon?

Read more »

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »